Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

947
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
947
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

644
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
644
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

676
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
676
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

635
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
635
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

758
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
758
Antiasthma Drugs: Leukotriene Modifiers01:19

Antiasthma Drugs: Leukotriene Modifiers

2.3K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
2.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The red eye.

The New England journal of medicine·2000
Same author

In vivo comparison of three different porous materials intended for use in a keratoprosthesis.

The British journal of ophthalmology·1998
Same author

Advances in polyvinyl alcohol hydrogel keratoprostheses: protection against ultraviolet light and fabrication by a molding process.

Journal of biomedical materials research·1997
Same author

Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids.

Archives of ophthalmology (Chicago, Ill. : 1960)·1996
Same author

Effect of pretreating porous webs on stromal fibroplasia in vivo.

Journal of biomedical materials research·1994
Same author

The Alcon Research Institute. A model for interaction between the pharmaceutical industry and academic medicine.

Archives of ophthalmology (Chicago, Ill. : 1960)·1993
Same journal

Home Tonometry and Perimetry: Addressing an Unmet Need in Glaucoma Care.

International ophthalmology clinics·2026
Same journal

Bleb Revision Techniques for Hypotony Maculopathy: A Review.

International ophthalmology clinics·2026
Same journal

Cyclodialysis Cleft Closure Following Suprachoroidal Spacer Implantation.

International ophthalmology clinics·2026
Same journal

Descemet Membrane Detachment During Ab-Interno Canaloplasty.

International ophthalmology clinics·2026
Same journal

Inflammatory Keratitis and IOP Spike After Repeat SLT in Pseudoexfoliation Glaucoma: Case Report and Literature Review.

International ophthalmology clinics·2026
Same journal

Beyond the Bottle: Lessons From the Laser in Glaucoma and Ocular Hypertension Trial.

International ophthalmology clinics·2026
See all related articles

Related Experiment Video

Updated: Mar 31, 2026

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
04:50

Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

Published on: May 16, 2025

1.4K

Antiinflammatory medications

H M Leibowitz, A Kupferman

    International Ophthalmology Clinics
    |January 1, 1980
    PubMed
    Summary
    This summary is machine-generated.

    Prednisolone acetate is the most effective corticosteroid for ocular inflammation. Frequent topical application significantly enhances its anti-inflammatory effects on the cornea.

    More Related Videos

    Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
    06:54

    Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

    Published on: November 15, 2024

    3.0K
    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
    07:50

    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

    Published on: July 16, 2012

    14.9K

    Related Experiment Videos

    Last Updated: Mar 31, 2026

    Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain
    04:50

    Preliminary Study on Acupuncture Combined with Grain-sized Moxibustion for Treating Rheumatoid Arthritis with Finger Joint Pain

    Published on: May 16, 2025

    1.4K
    Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice
    06:54

    Author Spotlight: Enhanced Method for Evaluating Analgesic Effects — Dual Hind Paw Carrageenan Injection in Mice

    Published on: November 15, 2024

    3.0K
    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
    07:50

    Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

    Published on: July 16, 2012

    14.9K

    Area of Science:

    • Ophthalmology
    • Pharmacology

    Background:

    • Corticosteroids are primary treatments for ocular inflammation.
    • Different corticosteroid derivatives exhibit varying anti-inflammatory potencies.
    • Prednisolone acetate is a highly effective ophthalmic corticosteroid.

    Purpose of the Study:

    • To evaluate the anti-inflammatory efficacy of different corticosteroid derivatives and administration routes.
    • To determine optimal dosing frequencies for topical corticosteroids in treating corneal inflammation.

    Main Methods:

    • Comparison of anti-inflammatory effects of various corticosteroid derivatives.
    • Assessment of different topical instillation frequencies of prednisolone acetate.
    • Evaluation of topical versus periocular corticosteroid administration.
    • Analysis of combined topical corticosteroid and antibiotic therapy.
    • Review of corticosteroid use in viral and fungal keratitis.

    Main Results:

    • Acetate derivatives are generally the most potent anti-inflammatory agents.
    • 1.0% prednisolone acetate demonstrates maximal anti-inflammatory effect.
    • More frequent topical instillation (hourly or every 15 minutes) yields superior results compared to less frequent dosing (every 4 hours).
    • Topical corticosteroid instillation is more effective than periocular injection for reducing corneal inflammatory cells.
    • Concurrent topical and subconjunctival corticosteroid administration shows additive effects.
    • Topical corticosteroids do not increase bacterial replication when used with antibiotics at appropriate frequencies.
    • Corticosteroids are contraindicated in active epithelial herpetic keratitis but may be useful in stromal herpetic keratitis.
    • Corticosteroids should be avoided in mycotic keratitis.

    Conclusions:

    • Prednisolone acetate is a preferred agent for maximal anti-inflammatory effect in ocular inflammation.
    • Optimizing topical corticosteroid instillation frequency is crucial for therapeutic outcomes.
    • Corticosteroids have specific contraindications in certain infectious keratitis cases (viral, fungal).
    • Judicious use of corticosteroids, in conjunction with other therapies, is essential for managing ocular inflammation effectively.